entertainment -WSS

entertainment

author：entertainment 2025-09-30 17:05:03 - browse：9

Christopher Viehbacher on stage at the 2023 STAT Summit. — Biogen CEO Christopher Viehbacher STAT

Two years after a big scientific swing nearly pushed Biogen to the brink, CEO Christopher Viehbacher is embarking on a corporate rethink, one that balances Biogen’s characteristic risky bets with a frank commitment to pragmatism.

Speaking at the STAT Summit in Boston on Thursday, Viehbacher said his Biogen predecessors fell off track through a few unsound investments and an all-or-nothing bet on Aduhelm, the Alzheimer’s disease treatment that became a pharmaceutical cautionary tale. Viehbacher, one year into his tenure at the storied company, said Biogen’s future will rely on taking a more disciplined approach to risk.

“There’s a huge amount of pride inside the company that we go after problems other people don’t,” Viehbacher said, “but at the end of the day you also have to get medicines through the pipeline to benefit patients, and that’s why we’re expanding the aperture of what we’re doing in R&D.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： MD Anderson's Padmanee Sharma responds to research credit suit

focus

WSS

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Researchers tackle phage therapy hurdles for wider adoption

Congress may force more Covid

Clinicians often fail to acknowledge the pain caused by long Covid

Flagship Pioneering startup Sonata Therapeutics lays off 21

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

focus

entertainment

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Louisiana bill approved classifying abortion pills as controlled substances

Apple is now the first public company to be valued at $3 trillion

Decentralized clinical trials need collaboration to achieve wider use

Malaria cases in Florida and Texas: Here’s what you need to know

Medical students need to learn the potent medicine of empathy

Wildfire smoke exposes gaps in outdoor worker protections

Congress may force more Covid

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

knowledge

Obamacare plans could cover weight loss drugs

New research sheds light on how often breast cancer is overdiagnosed

Decentralized clinical trials need collaboration to achieve wider use

Reporting on presidential health from Reagan to Trump and Biden

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Why we need mandatory labeling of GMO products

hotspot

focus

focus

focus